Clinical Utility of Polygenic Risk Scores Questioned in Commentary

Feb 04, 2019

|

Premium

NEW YORK (GenomeWeb) – A commentary published in Genetics in Medicine last month has led to discussion about the clinical utility of polygenic risk scores (PRS) for assessing an individual's risk of developing diseases such as heart disease or cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

Recent Headlines from
Precision Oncology News

The Scan

Asked to Give DNA Back

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

CCR5 Gene Mortality Paper Retracted

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

Catch It Before Being Hospitalized

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

PNAS Studies Look at Lung Cancer Models, Height in Ancient Europeans, More

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.

Featured White Papers

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay

Multiplexed Infectious Disease Analysis

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Oct

21

Featured Webinar

Broad Genomic Testing for Oncology Clinical Trials and Clinical Practice

Genomics is a key element in the potential of precision medicine to transform oncology.

Oct

23

Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.

Oct

24

Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov

04

Featured Webinar

Digital Solutions for NGS Genotyping – Accuracy, Clinical Relevancy, and Report Generation

This webinar will provide a look at how the Institute of Hematopathology in Hamburg, Germany, is implementing complex genomic testing for lung cancer.

Menu